Skip to main content
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. — Investor Relations & Filings

Ticker · WHWK ISIN · US00032Q1040 LEI · 549300G3U7TKW1M58L09 US Professional, scientific and technical activities
Filings indexed 514 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country US United States of America
Listing US WHWK

About Whitehawk Therapeutics, Inc.

https://ir.whitehawktx.com/

Whitehawk Therapeutics, Inc. is a preclinical-stage oncology company focused on developing advanced antibody-drug conjugate (ADC) therapies. The company applies next-wave platform technologies to established tumor biology to create treatments for difficult-to-treat cancers. Its portfolio features three ADC assets, which are engineered to overcome the limitations of first-generation predecessors through improved tumor targeting and clinical strategies. These assets are in-licensed from WuXi Biologics under an exclusive agreement for global development and commercialization.

Recent filings

Filing Released Lang Actions
8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer)
Regulatory Filings
2026-05-13 English
8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer)
Regulatory Filings
2026-05-07 English
3 Filing
Director's Dealing
2025-12-02 English
4 Filing
Director's Dealing
2025-12-02 English
10-Q Filing
Interim / Quarterly Report Q3 2025
2025-11-06 English
8-K Filing
Regulatory Filings
2025-11-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.